Giedrė Balčiūnaitė

Dr. Giedrė Balčiūnaitė

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Hellenic Journal of Cardiology
Verified
Journal Article
Open access
GBGiedrė Balčiūnaitė
Giedrė Balčiūnaitė
ARArnas Rimkus
Arnas Rimkus
EZEdvardas Zurauskas
Edvardas Zurauskas
TZTomas Zaremba
Tomas Zaremba
DPDarius Palionis
Darius Palionis
VJVilius Janusauskas
Vilius Janusauskas
Transthyretin cardiac amyloidosis (ATTR-CA) is a challenging and underdiagnosed cause of heart failure. Advances in cardiac imaging have enabled noninvasive diagnosis of ATTR-CA, causing the recent upsurge in disease awareness and detection. ATTR-CA has been increasingly recognized in patients with degenerative aortic stenosis (AS). With the growing number of elderly patients undergoing aortic valve intervention, the identification of ATTR-CA in this group of patients is of high clinical importance. Timely and correct diagnosis is essential for amyloid-directed therapies, as well as deciding on the AS treatment strategy. This review provides a comprehensive overview of the recent studies investigating coexistence of these two entities. We present the data on the prevalence of ATTR-CA in AS and their prognostic associations. As the diagnosis of ATTR-CA may be challenging, special attention is paid to the diagnostic utility of different imaging modalities, namely, echocardiography, cardiovascular magnetic resonance, nuclear imaging, and distinctive imaging features, in patients with dual pathology. We also present a flowchart summarizing integrated imaging in patients with suspected ATTR-CA.

12 August 2019 in European Radiology
Verified
Journal Article
Closed access
GBGiedrė Balčiūnaitė
Giedrė Balčiūnaitė
VSViktor Skorniakov
Viktor Skorniakov
ARArnas Rimkus
Arnas Rimkus
TZTomas Zaremba
Tomas Zaremba
DPDarius Palionis
Darius Palionis
SGSigita Glaveckaite
Sigita Glaveckaite

3 March 2022 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
GBGiedrė Balčiūnaitė
Giedrė Balčiūnaitė
JBJustinas Besusparis
Justinas Besusparis
DPDarius Palionis
Darius Palionis
EŽEdvardas Žurauskas
Edvardas Žurauskas
VSViktor Skorniakov
Viktor Skorniakov
SGSigita Glaveckaitė
Sigita Glaveckaitė

8 June 2020 in BMC Cardiovascular Disorders
Verified
Journal Article
Open access
PDF file
GBGiedrė Balčiūnaitė
Giedrė Balčiūnaitė
DPDarius Palionis
Darius Palionis
EŽEdvardas Žurauskas
Edvardas Žurauskas
VSViktor Skorniakov
Viktor Skorniakov
VJVilius Janušauskas
Vilius Janušauskas
SGSigita Glaveckaitė
Sigita Glaveckaitė
Background: Adverse cardiac remodeling with a myocardial fibrosis as a key pathophysiologic component may be associated to worse survival in aortic stenosis (AS) patients. Therefore, with the application of advanced cardiac imaging we aim to investigate left ventricular myocardial fibrosis in severe AS patients undergoing aortic valve replacement (AVR) and determine its impact with post-intervention clinical outcomes. Methods: In a prospective, observational, cohort study patients with severe AS scheduled either for surgical or transcatheter AVR will be recruited from two tertiary heart centers in Denmark and Lithuania. All patients will receive standard of care in accordance with the current guidelines and will undergo additional imaging testing before and after AVR: echocardiography with deformation analysis and cardiovascular magnetic resonance (CMR) with T1 parametric mapping. Those undergoing surgical AVR will also have a myocardial biopsy sampled at the time of a surgery for histological validation. Patients will be recruited over a 2-year period and followed up to 2 years to ascertain clinical outcomes. Follow-up CMR will be performed 12 months following AVR, and echocardiography with deformation analysis will be performed 3, 12, and 24 months following AVR. The study primary outcome is a composite of all-cause mortality and major adverse cardiovascular events. Discussion: Despite continuous effort of research community there is still a lack of early predictors of left ventricular decompensation in AS, which could improve patient risk stratification and guide the optimal timing for aortic valve intervention, before irreversible left ventricular damage occurs. Advanced cardiac imaging and CMR derived markers of diffuse myocardial fibrosis could be utilized for this purpose. FIB-AS study is intended to invasively and non-invasively assess diffuse myocardial fibrosis in AS patients and investigate its prognostic significance in post-interventional outcomes. The results of the study will expand the current knowledge of cardiac remodeling in AS and will bring additional data on myocardial fibrosis and its clinical implications following AVR. Ethics/dissemination: The study has full ethical approval and is actively recruiting patients. The results will be disseminated through scientific journals and conference presentations. Trial registration: ClinicalTrials.gov NCT03585933. Registered on 02 July 2018.

Verified
Journal Article
Open access
PDF file
DRDovile Ramanauskaite
Dovile Ramanauskaite
GBGiedrė Balčiūnaitė
Giedrė Balčiūnaitė
DPDarius Palionis
Darius Palionis
JBJustinas Besusparis
Justinas Besusparis
EZEdvardas Zurauskas
Edvardas Zurauskas
SGSigita Glaveckaitė
Sigita Glaveckaitė
Background: The presence of a relative apical sparing (RAS) echocardiographic strain pattern raises a suspicion of underlying cardiac amyloidosis (CA). However, it is also increasingly observed in patients with aortic stenosis (AS). We aimed to evaluate the prevalence, dynamics, and clinical characteristics of the RAS strain pattern in severe AS patients who had been referred for surgical aortic valve replacement (SAVR). Methods: A total of 77 patients with severe AS and without CA were included with a mean age of 70 (62–73) years, 58% female, a mean aortic valve area index of 0.45 ± 0.1 cm2/m2, and a mean gradient of 54.9 (45–70) mmHg. Results: An RAS strain pattern was detected in 14 (18%) patients. RAS-positive patients had a significantly higher LV mass index (125 ± 28 g/m2 vs. 91 ± 32, p = 0.001), a lower LV ejection fraction (62 ± 12 vs. 68 ± 13, p = 0.040), and lower global longitudinal strain (–14.9 ± 3 vs. –18.7 ± 5%, p = 0.002). RAS strain pattern-positive patients also had higher B-type natriuretic peptide (409 (161–961) vs. 119 (66–245) pg/L, p = 0.032) and high-sensitivity troponin I (15 (13–29) vs. 9 (5–18) pg/L, p = 0.026) levels. Detection of an RAS strain pattern was strongly associated with increased LV mass index (OR 1.03, 95% CI 1.01–1.06, p < 0.001). The RAS strain pattern had resolved in all patients by 3 months after SAVR. Conclusions: Our findings suggest that the RAS strain pattern can be present in patients with severe AS without evidence of CA. The presence of an RAS strain pattern is associated with adverse LV remodeling, and it resolves after SAVR.

27 August 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GBGiedrė Balčiūnaitė
Giedrė Balčiūnaitė
IRIeva Rudinskaitė
Ieva Rudinskaitė
DPDarius Palionis
Darius Palionis
JBJustinas Besusparis
Justinas Besusparis
EZEdvardas Zurauskas
Edvardas Zurauskas
SGSigita Glaveckaitė
Sigita Glaveckaitė
The optimal timing for aortic valve replacement (AVR) in aortic stenosis (AS) is still controversial and may be guided by markers of adverse left ventricular (LV) remodeling. We aim to assess electrocardiographic (ECG) strain in relation to LV remodeling and myocardial fibrosis. 83 severe AS patients underwent surgical AVR, with preoperative 12-lead ECG, cardiovascular magnetic resonance with T1 mapping and echocardiography with global longitudinal strain analysis. Collagen volume fraction (CVF) was measured in myocardial biopsies sampled during AVR. Patients with ECG strain had more severe AS, more advanced LV remodeling and evidence of heart failure. Patients with ECG strain had more diffuse fibrosis, as evident by higher mean native T1 values (974.8 ± 34 ms vs. 946.5 ± 28 ms, p < 0.001). ECG strain was the only predictor of increased LV mass index on multivariate regression analysis (OR = 7.10, 95% CI 1.46–34.48, p = 0.02). Patients with persistent ECG strain at 1 year following AVR had more advanced LV remodeling and more histological fibrosis (CVF 12.5% vs. 7.3%, p = 0.009) at baseline assessment. Therefore, ECG strain is a marker of adverse LV remodeling and interstitial myocardial fibrosis. Lack of improvement in ECG strain following AVR indicates more advanced baseline LV injury and higher levels of myocardial fibrosis.